Evidence map›Paper›PMID 28663437›Full record

ReviewCirculation. Cardiovascular quality and outcomes2017

2017 ACC/AAP/AHA Health Policy Statement on Opportunities and Challenges in Pediatric Drug Development: Learning From Sildenafil.

Craig A Sable, D Dunbar Ivy, Robert H Beekman, Helene D Clayton-Jeter, Kathy J Jenkins, William T Mahle, William R Morrow, Mary Dianne Murphy, Robert M Nelson, Geoffrey L Rosenthal and 2 more

Erratum issuedAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Circulation. Cardiovascular quality and outcomes, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Craig A SableAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
D Dunbar IvyAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
Robert H BeekmanAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
Helene D Clayton-JeterAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
Kathy J JenkinsAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
William T MahleAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
William R MorrowAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
Mary Dianne MurphyAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
Robert M NelsonAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
Geoffrey L RosenthalAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
Norman StockbridgeAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.
David L WesselAmerican College of Cardiology Representative. American Heart Association Representative. American Academy of Pediatrics Representative. US Food and Drug Administration Representative. Retired from the US Food and Drug Administration during the development of this statement.

Funding

Intramural FDA HHS FD999999
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdolescentAge FactorsChildChild, PreschoolDrug ApprovalDrug DevelopmentGovernment RegulationHealth PolicyHumansHypertension, PulmonaryInfantPatient SafetyPediatricsPhosphodiesterase 5 InhibitorsPolicy MakingRisk AssessmentPhosphodiesterase 5 InhibitorsSildenafil CitrateVasodilator AgentsAHA Scientific Statementsdrug developmentpediatric clinical trialssildenafilUS Food and Drug Administration

Identifiers

PMID28663437
PMCPMC5614492

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.